Get started
Author

Mustafa Şahbazlar

Observed names: M. Sahbazlar, MUSTAFA SAHBAZLAR, Mustafa Sahbazlar, Mustafa ŞAHBAZLAR, ŞAHBAZLAR, MUSTAFA
Observed institution: Manisa Celal Bayar University
ORCID: 0000-0003-1857-593X
Observed ORCID: 0000-0003-1857-593X
OpenAlex ID: A5021174559
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
2025 · Nadiye Sever, Fatih Şimşek, et al. · Journal of Clinical Medicine · 19
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study
2024 · Salih Tünbekici, Haydar cagatay Yuksel, et al. · Cancers · 13
PDF
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
2024 · Hasan Cagri Yildirim, Caner Kapar, et al. · Journal of Chemotherapy · 10
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
2024 · İsmail Beypınar, Hacer Demir, et al. · Breast Cancer Research and Treatment · 5
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab
2025 · Nagihan Kolkıran, Atike Pınar Erdoğan, et al. · Current Oncology · 4
PDF
Positive Lymph Node Ratio as a new prognostic score in Geriatric patients with operated gastric cancer
2024 · Omer Acar, Onur Yazdan Balcik, et al. · Heliyon · 4
SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer
2025 · Hikmet Akar, Ferhat Ekinci, et al. · Medicina · 3
PDF
Prognostic value of the HALP score in patients with testicular cancer: a retrospective study
2025 · Ahmet Burak Agaoglu, Atike Pınar Erdogan, et al. · Clinical & Translational Oncology · 3
PDF
Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study
2026 · Omer Acar, Ferhat Ekinci, et al. · Diagnostics · 2
PDF
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026 · Baris Koksal, Hasan Cagri Yildirim, et al. · Journal of Clinical Medicine · 2
PDF
IPI score as a new prognostic index in extensive stage small cell lung cancer
2025 · Ahmet Burak Ağaoğlu, Ferhat Ekinci, et al. · PeerJ · 2
PDF
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer
2025 · Ahmet Burak Agaoglu, Atike Pinar Erdogan, et al. · Medicina · 2
PDF
Exploratory evaluation of CA 15-3 × NLR score for predicting pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy
2025 · Emine Bihter Eniseler, Bartu Çetin, et al. · Clinical & Translational Oncology · 2
Real-Life Efficacy of Palbociclib and Ribociclib in Advanced Breast Cancer
2025 · Tugay Avci, Mustafa Sahbazlar, et al. · Current Oncology · 2
Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
2026 · Ece Sahin Hafizoglu, Ferhat Ekinci, et al. · Current Oncology · 1
Prognostic stratification using the Aarhus Composite Biomarker Score in recurrent and metastatic head and neck squamous cell carcinoma
2026 · Mustafa Şahbazlar, Melike Dönmez, et al. · European Archives of Oto-Rhino-Laryngology · 1
Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report
2026 · Melike Dönmez Tekin, Atike Pınar Erdoğan, et al. · BMC Urology · 1
Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group
2026 · Haydar Cagatay Yuksel, Elvina Almuradova, et al. · Frontiers in Oncology · 1
PDF
Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab
2026 · Ahmet Burak Agaoglu, Ferhat Ekinci, et al. · Clinical & Translational Oncology · 1
Systemic Inflammation and Nutritional Index as a prognostic marker in endometrial cancer
2026 · Nagihan Kolkıran, Atike Pınar Erdoğan, et al. · Biomolecules and Biomedicine · 1
PDF
Composite CA15-3, LDH, and Albumin Index as a Predictor of Survival in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
2026 · Nagihan Kolkıran, Atike Pınar Erdoğan, et al. · Pharmaceuticals · 1
Prognostic Value of the SUVmax–IPI Composite Score on Overall Survival in Metastatic Prostate Cancer
2026 · Emine Türkmen, Atike Pınar Erdoğan, et al. · Journal of Clinical Medicine · 1
PDF
Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)
2026 · Bengü Dursun, Şendağ Yaslıkaya, et al. · Cancers · 1
PDF
Nephrotoxicity secondary to CDK 4/6 inhibitors in advanced breast cancer patients and its impact on survival
2026 · Tugay Avci, Ahmet Anil Altunbas, et al. · Therapeutic Advances in Medical Oncology · 1
The Advanced Lung Cancer Inflammation Index: A Powerful and Independent Prognostic Factor in Metastatic Gastric Cancer
2025 · Tugay Avci, Mustafa Sahbazlar, et al. · Medicina · 1
PDF
Works count: 58
Citation count: 89
H-index: 4
I10-index: 3
Year
Topic
Type